- Human（1）
No data
- His Tag & Avi Tag（1）
No data
- HEK293（1）
No data
- Biotin-labeled（1）
No data
- RUO（1）
No data
- No（1）
No data
- 25ug/$125.00
- 200ug/$700.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| HLA-A*2601 & B2M | Biotinylated Human HLA-A*26:01&B2M Monomer Protein (Peptide free, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Latozinemab | AL-001; GSK-4527223 | Phase 3 Clinical | Alector Inc, Glaxosmithkline Plc | Bipolar Disorder; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Neurodegenerative Diseases | Details |
| VES-001 | VES-001; VES001 | Phase 1 Clinical | Vesper Bio APS | Dementia; Frontotemporal Dementia | Details |
